Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
AB, absolute, ADT, afflicted, afformentioned, Antegene, argue, ASP, ATM, Bio, bolster, California, Canadian, characteristic, cis, cleavage, CNS, collusion, combat, combo, commented, consecutive, constitutionality, cut, cyclophosphamide, dark, DBH, diffuse, disintegrin, DLBCL, Dohme, drew, driven, economy, effector, eighty, Eucure, evacuate, evergreen, Excellence, faulty, floating, FTI, GlaxoSmithKlein, grey, guarantor, hematological, Hodgkin, Horizon, HPV, hydroxydaunorubicin, ID, impermissible, impermissibly, inaccessible, Inferior, inoperable, IO, Johnson, Keytruda, leaflet, Leerink, leisure, linked, lymphoma, men, metalloproteinase, mistake, molcule, multitude, naive, Nanjing, neighboring, NHL, NSCLC, oncovin, override, overseen, paradigm, periphery, pioneering, plot, poorly, postponed, prednisone, PwC, Qilu, reclassified, Reg, Regeneron, relocate, repetition, revamp, rituximab, score, SD, Sharp, soft, software, soluble, SOX, Stingthera, subclaim, subscribe, subscribed, successor, supplementary, SVB, sweeping, Swimmer, TPS, Ukraine, und, underwent, unpatented, unsatisfactory, untreated, vaccinate, variously, Venture, Vermont, WAC
Removed:
accredited, biology, capacity, commit, comparison, concurrent, convenient, Dawson, deteriorate, EGC, ending, feedback, filer, furlough, governed, hire, implicated, indirect, interaction, irrevocably, manager, mandate, path, plc, presidential, proceed, redeemable, reproduce, reversed, revised, rotation, sampling, SBP, specificity, Sperovie, strain, unaudited
Filing tables
Filing exhibits
Related press release
Associated FSTX transcripts
FSTX similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-215122, 333-234436, 333-258783 and 333-254884) and S-8 (Nos. 333-212047, 333-226508, 333-252396, 333-251033, 333-243754, and 333-263170) of F-star Therapeutics, Inc. of our report dated March 30, 2021 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Cambridge, United Kingdom
March 15, 2022